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Abstract
Blepharitis and dry eye disease have long been viewed as two distinct diseases 
with overlapping presentations and separate etiologies. Evaporative dry eye, 
although frequently associated with aqueous deficiency, is also considered a sepa-
rate entity. We propose viewing dry eye, both evaporative and insufficiency, as the 
natural sequelae of chronic blepharitis induced by biofilm. We suggest describing 
this one chronic disease as dry eye blepharitis syndrome (DEBS). The disease pro-
cess begins when normal flora bacteria colonize the lid margin beginning shortly 
after birth. This colonization accompanies the development of a biofilm on the lid 
margin. As years pass, the biofilm matures, and the increased bacterial population 
initiates the production of inflammatory virulence factors, such as exotoxins, cyto-
lytic toxins, and super-antigens, which persist on the lid margin for the rest of the 
patient’s life. These virulence factors cause early follicular inflammation and later, 
meibomian gland dysfunction followed by aqueous insufficiency, and finally, after 
many decades, loss of the dense collagen in the tarsal plate. We proposed four stages 
of DEBS, which correlate with the clinical manifestations of folliculitis (anterior 
blepharitis), meibomitis (meibomian gland dysfunction), lacrimalitis (aqueous 
deficiency), and lid structure damage evidenced by increased lid laxity resulting in 
entropion, ectropion, and floppy eyelid syndrome.
Keywords: biofilm, blepharitis, demodex, dry eye disease, eyelids,  
meibomian glands, quorum-sensing gene activation, tear film
1. Introduction
Blepharitis was first described by ancient Egyptian physicians in the Ebers 
Papyrus, which prescribed potions such as “Cream with the Milk-of-a-Woman-
who-has-borne-a-Son” [1, 2]. Despite centuries of study, little progress has been 
made in understanding or treating this disease. The long standing dogma of mul-
tifactorial, overlapping manifestations of blepharitis and dry eye have led to the 
use of inaccurate terminology that creates misunderstanding among both patients 
and providers [3, 4]. In order to develop our understanding of DEBS, we must first 
establish the correct use of the word blepharitis as suggested by the origin of the 
word (blepharon = lid, −itis = inflammation).
The next step in understanding dry eye disease and blepharitis as a single 
disease process is to identify the cause of eyelid inflammation. In 1954, Thygeson 
first recognized that blepharitis was associated with “abnormal Staphylococcus 
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colonization” of the eyelid margin [5]. Thygeson was describing the process by 
which our normal lid margin flora bacteria, primarily Staphylococcus aureus and  
S. epidermidis, gradually over-colonize the patient’s lid margin, and over time, 
become pathogenic [6]. This is made possible by the bacterial biofilm, which 
allows the bacteria to thrive despite antimicrobials and the immune system [7]. 
Understanding biofilm progression links the shared underlying pathology between 
dry eye and blepharitis.
Biofilms are defined as groups of microbial cells enclosed in a matrix made 
primarily of polysaccharide material that are intimately associated with a surface. 
Antonie van Leeuwenhoek is credited for the first observations of biofilm, when 
he described the biofilm on teeth in 1684. However, further study of biofilms 
was limited until the development of the electron microscope in the mid-1900s. 
Furthermore, it was not until 1982 that the term “biofilm” was introduced, after 
Costerton’s observation of a S. aureus biofilm on a cardiac pacemaker lead [8]. More 
recent studies have shown that cell-to-cell interactions (“quorum sensing”) within 
the biofilm upregulate certain gene products. Further studies have implicated 
biofilm in many disease processes including periodontitis, endocarditis, chronic 
prostatitis, and medical device associated infections, as the one described by 
Costerton [8–10].
This chapter will explain the six steps by which our normal margin lid flora 
become pathogenic and cause eyelid inflammation. This inflammation, in turn, 
leads to the four stages of DEBS: folliculitis, meibomitis, lacrimalitis, and lid 
structure damage (Figure 1). This understanding will allow us to encompass dry 
eye disease, blepharitis, and meibomian gland dysfunction (MGD) in one disease 
process, namely, dry eye blepharitis syndrome (DEBS).
2. Biofilm
Bacteria were among the first forms of life on Earth and have survived billions of 
years in a myriad of different environments. While they are unicellular microorgan-
isms, and can live in a free-floating form, the development of a biofilm provides 
Figure 1. 
Biofilm theory of dry eye disease: Schematic of six steps of bacterial biofilm development leading to the stages of 
DEBS.
3
Biofilm Theory for Lid Margin and Dry Eye Disease
DOI: http://dx.doi.org/10.5772/intechopen.89969
them a strong, virtually impenetrable defense structure [8]. Furthermore, Absalon 
et al. and Pickering et al. suggest that free-floating bacteria are the minority in 
nature by describing the biofilm as “the prevailing microbial lifestyle” [11, 12].
The biofilm helps bacteria by acting as armor against host defense responses 
and desiccation. It enhances survival across species by allowing bacteria to produce 
virulence factors, concentrate nutrients, and communicate with other bacterial 
species [13]. Biofilms are involved in many infections and are present in almost 
any environment – they form plaque on the teeth and can lead to corrosion of 
metal pipes. They are involved in recurrent infections from medical devices – from 
sutures to prostheses. Although they can also be found as floating mats submerged 
in or on top of liquids, they are usually sticky and adhere easily to any surface 
[14]. For example, S. epidermidis and S. aureus produce a protein called “adhesin”, 
which functions as a glue, ensuring a strong adhesion between the biofilm and its 
host surface [15]. Once adhered, they are hard to dislodge, allowing the bacteria to 
remain in a desirable environment.
Biofilms are likely to grow wherever there is moisture, nutrients, and a surface 
[16]. These are all present at the lid margin, which has the added benefit of its 
inherent warmth. It is well known that the lid margin is home to normal flora bac-
teria consisting of mainly coagulase-negative species such as S. epidermidis [6]. It is 
also well known that species of Staphylococcus, especially S. epidermidis, produce 
biofilms [17]. In addition, a recent study by Kivanç demonstrated that 32 out of 
34 isolates cultured from eyes immediately after cataract surgery were positive for 
being biofilm-forming species [18]. Taking all this information into account, it 
should come as no surprise that biofilms easily develop on the lid margin.
Furthermore, to avoid irritating our eyes with soap when we wash our face, we 
instinctively keep our eyes tightly shut, lid margin against lid margin, effectively 
blocking access to an area that needs cleaning as much as or more than any other 
area of the body. Therefore, the biofilm accumulates microscopically year after 
year, layer upon layer, without any removal. Even if home scrubs are attempted, the 
adhesin “glue” can prevent biofilm elimination. As patients age, the biofilm contin-
ues to accrue, leading to each of the stages of DEBS over time. This process starts 
much earlier in contact lens wearers, since the contact lens is itself an inert foreign 
body, producing a very early biofilm that allows protection for bacteria. Biofilm 
formation on contact lens and contact lens cases has been well documented [19]. 
This also helps explain why dry eye disease is more common in contact lens wearers, 
50% compared to 14% in controls [20].
The biofilm forms a multi-laminar substrate that provides more surface area for 
bacterial replication, which in turn leads to vast over-colonization of the surface. 
The over-colonization within the biofilm and increase in bacterial population den-
sity is what leads to quorum-sensing gene activation [21]. The discovery of quorum-
sensing gene activation by Hastings in 1999, was a groundbreaking study that lead 
to increased understanding of bacterial virulence [22]. Hastings demonstrated that 
populations of bacteria can sense when their densities achieve a certain quorum, 
and once that number or density is reached, dormant genes are activated [23]. The 
bacteria signal to each other using chemical messengers called homoserine lactones 
(HSLs) as well as through electric currents produced by potassium ions [24]. When 
enough bacteria are in close proximity to each other, the signals from these the 
surrounding bacteria sum to indicate a quorum [25]. These newly activated genes 
produce a wide array of virulence factors, many of which are extremely inflam-
matory. The bacteria wait to produce these factors until they have the protective 
biofilm in place to shield from the host immune response [26]. The inflammation 
from the host response to these virulence factors is the real destructive force in 
inflammatory lid disease, causing low-grade, chronic inflammation, beginning on 
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the lid surface, the structures of the lid margin such as lash follicles, meibomian 
glands and connective tissue, and eventually affecting the accessory lacrimal glands 
as it progresses.
S. epidermidis produces a small amount of a moderate cytolytic toxin, a phenol-
soluble modulin, but S. aureus produces two groups of highly destructive and 
immunogenic exoproteins: exotoxins and enzymes [27–29]. Many exotoxins are 
super-antigens that signal T cells to secrete large amounts of cytokines, and thus, 
massive inflammation. Exotoxins are responsible for toxic shock syndrome, food 
poisoning and scalded skin syndrome (toxic shock syndrome toxin, staphylococcal 
enterotoxins A-E and G-I, and exfoliative toxins A and B respectively) [30, 31]. 
The enzymes produced consist of nucleases, proteases, lipases, hyaluronidase, and 
collagenase, all capable of destroying host tissue [32]. Cytolytic toxins, including 
hemolysins and leukocidins, further contribute to the inflammatory cascade by 
destroying or damaging cells [33].
These toxins and enzymes permeate the biofilm and its surroundings, creating 
the same massive inflammation that leads to acute, severe debilitating disease as in 
scalded skin syndrome, food poisoning, and even death, as in the case of toxic shock 
syndrome [34]. As the biofilm spreads, more areas reach the quorum needed to acti-
vate virulence factors. Thus, inflammation spreads from the lid margin, to within 
the lash follicles, meibomian glands, accessory lacrimal glands, possibly to the main 
lacrimal gland and eventually to nerve endings and even the connective tissue of 
the eyelid, which can affect the structural integrity of the eyelids [35]. Decades of 
this toxicity, and the resulting inflammation, leads to nonselective damage [36]. 
While the body manages to ward off some of the effects of this toxic environment 
until later in life, eventually no part of the lid is immune to this chronic, progressive 
inflammation [37].
3. The four stages of DEBS
As we have now established that inflammatory lid disease is due to the inflam-
matory response to virulence factors produced by a mature biofilm, we can proceed 
to understanding the various clinical manifestations of DEBS. The important 
factors to consider are lid anatomy, duration of biofilm presence and associated 
virulence factors along the lid margin. False descriptions such as anterior, poste-
rior, staphylococcal or seborrheic do not accurately describe the stage of blepha-
ritis, and merely serve as distractors. Instead, it is important to understand that 
inflammation is an inevitable consequence of virulence factor production, and it 
does not discriminate among structures of the lid. It simply takes some structures 
longer to be affected than others because of anatomy. Due to sticky proteins such 
as adhesin, as well as the biofilm’s innate defense against antimicrobials and the 
immune system, the biofilm usually remains in place for most of the patient’s life 
[38, 39]. This allows the inflammation to eventually affect all structures within 
the eyelid.
The biofilm is likely formed early in the patient’s life, around the toddler stage. 
This early biofilm does not cause pathology in most cases because the densities 
of bacteria within the biofilm have not reached the quorum required to activate 
virulence factors. There are certainly exceptions, where children present with 
severe blepharitis [40]. These children likely have two particularly virulent strains 
of bacteria colonizing their eyelids simultaneously. The first is likely a hyper-
virulent strain of S. epidermidis, which makes copious biofilm, and the second is a 
particularly virulent strain of S. aureus, whose quorum for gene activation is lower 
than normal [41] and whose toxins are more destructive. Further research into these 
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children’s lid flora would help clarify the variation in pathogenesis. Other factors 
such as rosacea and Demodex also remain to be investigated.
In the majority of the population, the biofilm must be present for decades before 
enough bacteria accumulate to reach a quorum [42]. As previously mentioned, bio-
films form wherever there is a “combination of moisture, nutrients and a surface” 
[16]. Therefore, the lid margin, which provides all three of these requirements, is 
a logical starting point for the development of the biofilm. The lid margin includes 
the lash line and extends just past the openings of the meibomian glands [43]. Other 
areas of the ocular surface are better defended from the development of biofilm. 
Specifically, the mechanical sweeping and flushing of tears protects the palpebral 
and bulbar conjunctiva, while antibacterial lactoferrin and lysozyme protect the 
tear film [44–46]. Goblet cells provide further protection to the epithelial surfaces 
by secreting mucus [47].
Despite its antimicrobial protein content, the majority of the protection given by 
mucus is due to its mechanical characteristics. In the large intestine, there are two 
layers of mucus: the outer one houses gut bacteria, and the inner, impermeable layer 
prevents the underlying epithelial cells from bacterial invasion [48, 49]. While the 
small intestine lacks the inner layer, it still prevents bacterial exposure by creating 
a diffusion gradient with a rapid turnover that bacteria must overcome to access 
the epithelial cells [50]. Mucus trapping bacteria also prevent antigen presentation, 
which limits immune response. These functions may well help protect the conjunc-
tiva as well – limiting environmental antigen presentation and forming an impen-
etrable barrier. In addition, the rapid turnover combined with the sweeping action 
of blinking creates an unstable surface to which a biofilm cannot adhere. Therefore, 
maintenance of a healthy population of goblet cells is essential to prevent biofilm 
buildup on the conjunctiva.
We know that the mucus is permeable to other molecules such as antibiotics, ste-
roids, other medicated eye drops, therefore it is logical to assume that at least some 
of the exotoxins, enzymes and cytolytic toxins can reach the epithelia. Similarly, if 
virulence factors behave like the molecules in eye drops, it may be possible for them 
to slowly penetrate into the eye and damage structures within the eye; for example, 
the trabecular meshwork. Perhaps the meshwork simply becomes “sticky” due to 
subclinical inflammation and more easily traps protein, white cells or RBCs. This 
could occur through either subclinical inflammation or direct damage from cyto-
lytic toxins and enzymes. If this is the case, it may in part explain why the incidence 
of glaucoma increases with age: a thicker biofilm releases more toxins which can 
damage lid margin structures and internal eye structures over time.
The manifestations of DEBS vary depending on the stage of the disease, which 
progresses exceedingly slowly. These differing presentations have led to confu-
sion as to the presentation and progression of blepharitis and dry eye disease. This 
confusion stems from focusing on the presenting problem and not understanding 
what preceded it. For instance, if a patient has meibomian gland dysfunction, the 
diagnosis is made of evaporative dry eye disease, without further consideration 
of the lash follicles [51]. Similarly, if there is inadequate tear lake, the patient is 
diagnosed with aqueous insufficiency, ignoring the status of the meibomian glands 
[52, 53]. We hope to eliminate this confusion by dividing DEBS into four stages 
and by making a logical argument for the order of this progression based on eyelid 
anatomy and histology.
3.1 Stage 1: folliculitis (anterior blepharitis)
The first stage of DEBS involves the lash follicles. The potential space between 
the eyelash and the follicle surrounding it is easily invaded by the biofilm 
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(Figure 2). Once quorum densities are achieved and virulence factor production 
begins, the small lash bulb can become inflamed relatively quickly. Inflammation 
leads to edema, which can be clinically identified with the “volcano” sign – swollen 
follicular tissue around the base of the lash (Figure 3). The swollen tissue may also 
appear pale, possibly due transudate and/or capillary compression due to edema. 
The biofilm that adheres to the lash will be pulled along as the lash grows, result-
ing in “collarettes” (Figure 4). These collarettes have also been called scurf, debris 
or lash dandruff. Because they originate from biofilm, they appear at different 
levels on the eyelash, depending on the lash’s growth stage. Near the top of the 
lashes in Figure 4, it is possible to see collarettes just beginning to detach from the 
lid margin. This biofilm growth can also manifest as “cylindrical dandruff” [54]. 
Despite the term “dandruff,” it is unlikely that sloughing layers of skin could form a 
cylinder around the eyelash. Thus, this term is most likely an inaccurate description 
of biofilm that accumulates around the lash base and sheathes the lash as it grows. 
Since the lash follicles are likely damaged through inflammation, the growth of the 
lash is slowed, which enables the biofilm accumulation to progress at the same rate 
as lash growth [55]. We have confirmed the presence of bacterial colonies in the 
scurf around lashes (Figure 5), and fluorescence microscopy was consistent with 
biofilm matrix around the lash [55].
A 2005 article by Gao et al. proposed that cylindrical dandruff was pathognomic 
for Demodex, which found that all their subjects who presented with cylindrical 
dandruff also had Demodex. While other studies had different findings, Gao et al. 
explained the discrepancy as “miscounting” by the other researchers [54]. However, 
even if the 100% incidence in this one study is completely accurate, correlation 
does not necessarily establish causation. A later article by Tsubota et al. found that 
“Demodex was detected in the cilia of 8 out of 10 (80%), and 22 cilia out of 30 
(73%) with cylindrical dandruff” [56]. While these numbers certainly suggest an 
association, they do not imply causality. In fact, since Demodex were not detected 
in all of the lashes, it would suggest a lack of causality. Furthermore, Demodex 
does not extrude waste, instead storing it in its gut, which makes it unlikely that 
they secrete the dandruff [63]. It is much more likely that the eyelids accumulate 
an abundance of biofilm over time, which progresses along with eyelash growth, 
Figure 2. 
Scanning electron microscopy of an eyelash hair shaft showing potential biofilm.
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and that Demodex uses the polysaccharide biofilm as a rich source of nutrition. The 
cylindrical dandruff is likely a combination of Demodex carcasses and biofilm.
Collarettes, clumping, eye discharge, and sticky eyelids upon awakening are all 
evidence of bacterial biofilm along the lid margin. However, they are not required 
for diagnosis of blepharitis. In patients with late-stage disease, there may be sig-
nificant lid inflammation without scurf. Though this may seem to be incongruous 
with blepharitis, the likely 40–50 years of inflammation at this stage have so badly 
damaged the eyelash bulb that the lashes are either barely growing or not growing 
at all. Therefore, there is no scurf, because there has been no/minimal lash growth 
to pull it away from the lid margin. Therefore, a paucity of lashes, in association 
with swollen lash follicles, as shown in Figure 3, can also indicate DEBS. In addi-
tion, these late-stage patients typically have exceedingly dry lid margins, which 
inhibit further biofilm production. In other words, bacteria can eventually become 
their own worst enemy by destroying the very moisture that is required for biofilm 
production.
3.2 Stage 2: meibomitis (MGD)
The next stage of DEBS involves the spread of inflammation from the lash fol-
licles to the meibomian glands. These glands are relatively more protected than the 
follicles due to their narrow ductules and the constant flow of meibum out of the 
gland. These characteristics ensure that meibomian involvement occurs after fol-
licular involvement. Meibomian glands are also 5–10 times larger than lash follicles, 
which means that inflammation takes longer to significantly hinder the working 
of the gland than the follicle [57]. The amount of time between Stage 1 and Stage 2 
Figure 3. 
The pallor around the lash follicles indicates the “volcano” sign associated with folliculitis.
Figure 4. 
Collarettes/cylindrical dandruff present on the lashes.
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depends on the virulence and biofilm production characteristics of the patient’s par-
ticular bacterial profile, but we estimate approximately 10–15 years between them.
Obvious vs. nonobvious MGD is a recent topic of discussion and can also be 
explained through understanding the biofilm. Obvious MGD manifests with 
inspissation and capping (domes over gland openings) that can be observed on 
exam (Figure 6). On the other hand, nonobvious MGD does not have these mani-
festations. Nonobvious MGD can be thought of as the biofilm forming layers within 
the gland and starting the inflammatory process [58]. As the biofilm accumulates 
within the gland and mixes with meibum, it eventually blocks the narrow ductule, 
thereby causing obstruction. This thickened mixture of biofilm and meibum takes 
on a “toothpaste” quality and may alter the consistency of the lipid profile of the 
meibum, either through the presence of abnormal lipids or decreased overall lipid 
secretion [59]. The mixture of meibum with biofilm has an increased melting point, 
which leads to thickening and obstruction. These secretions may not be expressed 
because the meibomian glands are large and the biofilm may not have affected a sig-
nificant enough portion of them yet, therefore leading to nonobvious MGD. Once 
the gland is full of the thick meibum and biofilm mixture, the secretions will have 
Figure 5. 
Transmission electron microscopy of cylindrical dandruff showing bacterial colonies (blue circles), which 
suggests that the dandruff is likely biofilm.
Figure 6. 
Evidence of meibomian gland dysfunction showing inspissation and capping.
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nowhere further to accumulate within the gland and will attempt to move up and 
out of the ductule. However, the original biofilm traps these secretions forming 
small whitish domes similar in color to what is observed within an early non-
obvious occluded ductule. Expression of the glands may release copious amounts 
of sludge or inspissated secretions. While the composition of the peaks or caps has 
never been effectively studied, it is not difficult to imagine that they are composed 
of accumulated “altered” meibum mixed with biofilm covered by a more “pure” 
biofilm [60]. Therefore, the filling of the gland past its capacity is what triggers the 
appearance of the “domes” in obvious MGD, but it is the thickened biofilm mixture 
which has reached quorum-sensing that begins the early, and later obvious, signs 
of overt inflammation along the posterior lid margin [61]. Hence, the difference 
between obvious and nonobvious MGD is simply one of degree.
3.3 Stage 3: lacrimalitis (aqueous deficiency)
Stage 3 DEBS involvement of the accessory lacrimal glands of Wolfring and 
Krause, and probably the main lacrimal gland, leads to aqueous deficiency. There 
are approximately 30 lacrimal glands of Krause and about 5 glands of Wolfring 
on each eye. They are responsible for baseline aqueous production [62, 63]. The 
ducts of these glands empty along the inside lid, up near the fornices. The distance 
from the lid margin biofilm, the narrow ducts, and the constant flushing activ-
ity of tear production all serve to protect these glands from activity along the lid 
margin. However, the biofilm can spread from the lid margin by being shed into 
the tear film, and decades of shedding eventually leads to some biofilm infiltrating 
the glands of Krause and Wolfring. Alternatively, it is quite possible that a layer of 
biofilm, kept attenuated due to constant flushing and lid/eye movement, neverthe-
less eventually reaches these glands by direct extension. Because of their innately 
protective distance from the lid margin, these glands are the last group to become 
infiltrated by biofilm, and therefore, the last to succumb to the effects of inflamma-
tory damage from biofilm virulence factors. This is supported by looking at clinical 
manifestations of patients with many of the symptoms of dry eye – burning, irrita-
tion, and difficulty seeing – in conjunction with excessive tearing. While exam may 
lead to diagnosis of evaporative dry eye with a deficient lipid layer, patients may not 
understand how they could have dry yet watery eyes. These patients have deficient 
lipid production but intact aqueous production, indicating diseased meibomian 
glands but still healthy accessory glands of Krause and Wolfring. On the other hand, 
unless there is an autoimmune disorder, it is virtually impossible to see an aqueous-
deficient patient without MGD (Figure 7). This finding supports the conclusion 
that aqueous deficiency presents after evaporative dry eye due to the accessory 
lacrimal glands being affected after the meibomian glands.
By the time we have Stage 3 DEBS, the follicles have been subjected to chronic 
inflammation for many decades and are sometimes so badly damaged that lash 
growth is arrested, and hence, there may be little-to-no biofilm noted among the 
eyelashes. Lashes fall out and may not regrow or regrow very slowly. Looking 
closely, one will typically find significant swelling around the base of the lash along 
with pallor as in Stage 1.
3.4 Stage 4: lid destruction
Stage 4 DEBS is marked by the breakdown of the structural integrity of the 
eyelid. Lid laxity, entropion, ectropion, and floppy eyelid syndrome are often mani-
festations of end-stage chronic inflammatory lid disease [64]. The inflammation 
associated with the formation of the biofilm eventually affects connective tissue, 
Ocular Surface Diseases - Some Current Date on Tear Film Problem and Keratoconic Diagnosis
10
muscle, and nerve endings within the lid margin, which become damaged and lose 
their functionality [65]. Because of the loss of the nerve endings, these patients are 
often asymptomatic. Also, as mentioned prior, since bacteria need moisture to grow 
and produce biofilms, years of dry eye may degrade their once-ideal environment to 
the point where they cannot sustain large colonies of bacteria, these patients often 
present with little to no biofilm. By this point, however, the damage to the lid and 
the tear glands is already done and may be irreversible.
3.5 Management
The armor provided by the polysaccharide matrix of the biofilm explains why 
many novel treatments proposed in the past 100 years have failed. The only treat-
ment for chronic blepharitis universally agreed upon is lid hygiene [66]. Historically 
we have preferred simple salt water soaks [67]. Recently, microblepharoexfoliation 
(MBE) has become available [68]. This additional form of lid hygiene provides a 
thorough mechanical biofilm removal of the lid margin, which may have a pro-
found impact on patient’s symptoms, quality of tears, and quality of life. Therefore, 
we propose performing MBE of patients’ lids, with electric rotary sponge cleaning, 
in an effort to remove the biofilm and prevent and/or slow down the progression of 
DEBS (Figure 8).
Besides the treatment of DEBS, MBE may have other potential roles in oph-
thalmology. It is known that endophthalmitis is most commonly associated with 
the presence of biofilm-forming bacteria in the patients’ lid margin. The afore-
mentioned Kivanç study demonstrated that these biofilm formers are present and 
can survive a Betadine wash [18]. By performing a thorough MBE of the patient’s 
lids, we may be able to reduce the incidence of post-cataract infection. In addition, 
by removing the biofilm from the lid margin and meibomian glands, we should 
expect a better tear film and therefore more accurate pre-operative screening and, 
more importantly, better post-op vision. Similarly, patients undergoing refractive 
surgery, such as laser in situ keratomileusis, photorefractive keratectomy, and 
phototherapeutic keratectomy, and contact lens wearers will probably also benefit 
from an electromechanical debridement of their lid margin. All of these patients 
may benefit from the reduction or elimination of the progression of the lid biofilm 
with yearly electromechanical debridement.
Figure 7. 
Eye showing both aqueous deficiency (positive staining with rose Bengal) and meibomian gland dysfunction 
(pouting of glands).
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4. Conclusions
Understanding DEBS as a singular disease process that presents in stages, over 
decades, throughout a person’s lifetime allows us to successfully explain all clini-
cal scenarios we encounter. DEBS explains the overlap of the so-called anterior 
blepharitis with posterior blepharitis, why we do not see isolated cases of aqueous 
deficiency and why the disease worsens with age. It also shows why some patients 
may become asymptomatic and why we sometimes do not see biofilm within the 
lash line despite severe lid disease findings. Finally, DEBS also describes chronic 
changes to the structural integrity of the eyelids, including lash loss.
Dentists have done a masterful job in educating patients as to the importance 
of routine oral hygiene. “Plaque” has become a household term for dental biofilm. 
While in the past years of biofilm-related inflammation caused elderly patients to 
require dentures, patient education is helping full dentures become obsolete. In 
2006, a CDC report claimed “the baby boomer generation will be the first where the 
majority will maintain their natural teeth over their entire lifetime” [69].
We too can improve patient outcomes by preventing damage to the critically 
important meibomian glands and other eyelid structures, rather than reacting to 
the damage once it is already done. To prevent DEBS, we need to make routine lid 
hygiene akin to “brushing your teeth” and electromechanical debridement as com-
monplace as routine dental cleaning. This is now possible, but it must start with a 
new understanding of DEBS, and an active role by the ophthalmologist stressing lid 
hygiene and advocating for regular MBE procedures on all patients, the sooner the 
better, particularly on those at higher risk.
Figure 8. 
Upper lid lash margin showing presence of cylindrical dandruff and “scurf”. Top: Before MBE; Bottom: After 
MBE (Courtesy of BlephEx, Inc.).
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Appendices and nomenclature
Biofilm     Groups of microbial cells enclosed in a 
matrix of primarily polysaccharide mate-
rial that are intimately associated with a 
surface
Blepharitis    Inflammation of the eyelid
Cylindrical dandruff    Sleeve of material that forms around the 
eyelash, likely due to biofilm accumula-
tion combined with eyelash growth
DEBS     Dry Eye Blepharitis Syndrome; a pro-
posed unifying diagnosis that links 
both dry eye and blepharitis as stages of 
inflammation caused by progression of 
biofilm
Goblet cells     Specialized epithelial cells that secrete 
mucus, helping maintain the barrier 
against pathogens
Microblepharoexfoliation (MBE)   Lid margin cleaning, with electric rotary 
sponge, in an effort to remove accumu-
lated biofilm
Virulence factors    Factors released by bacteria that cause 
inflammation, including exotoxins, 
enzymes, super-antigens and cytolytic 
toxins
Volcano sign     Swollen, follicular tissue around the base 
of the lash
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